Skip to main content
OpenTrials

Clinical trial condition

Relapsing-Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing-Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

98 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Relapsing-Remitting Multiple Sclerosis trial results

Completed

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT02283853

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • The Rector and Visitors of the University of Virginia Charlottesville, Virginia, United States
  • Universitair Kinderziekenhuis Koningin Fabiola Brussels, Belgium
  • Universitair Ziekenhuis Ghent Ghent, Belgium
View all 62 locations
View Trial Details
Completed

Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

NCT04940065

Conditions
Active Secondary Progressive Multiple Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +7 more
Locations
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Nagakute, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
View all 103 locations
View Trial Details
Completed

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

NCT04997148

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • University Hospitals Coventry and Warwickshire- Neurology Coventry, United Kingdom
  • NHS Lanarkshire Health Board- Department of Neurology Glasgow, United Kingdom
  • Queen Elizabeth University Hospital Glasgow, United Kingdom
  • University Hospitals of Leicester NHS Trust Leicester, United Kingdom
View Trial Details
Completed

Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt

NCT05423769

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Neuropsychiatry department, Faculty of Medicine, Alexandria University Hospitals, Hadra University Hospital Alexandria, Egypt
  • Faculty of medicine Ain shams Research Institute-Clinical Research Center (MASRI-CRC) Cairo, Egypt
View Trial Details
Completed

Tysabri Observational Program

NCT00493298

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations
  • Research Site Buenos Aires, Argentina
  • Research Site Buenos Aires, Argentina
  • Research Site Buenos Aires, Argentina
  • Research Site Buenos Aires, Argentina
View all 419 locations
View Trial Details

Related conditions